Liquid biopsy study for solid tumours and brain tumours
Part of Brain & nervous system, Cancer clinical trials.
This study collects samples of spinal fluid and blood from people with solid tumours that have spread to the brain or spine, or who have primary brain tumours. The goal is see if these samples can help doctors detect and monitor these cancers more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a solid tumour that has spread to the fluid around your brain and spine, or to your brain, or to other parts of your body, or you have a primary brain tumour.
- You are able to have a lumbar puncture (spinal tap) or have a device called an Ommaya reservoir already in place to collect spinal fluid.
- You have not yet had treatment for this condition, or your current treatments have stopped working and your disease is worsening.
- You can be at any point in your treatment, even if you just started or have been treated before.
- You do not have any medical reason that makes a spinal tap unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with solid tumors that have spread to the brain (including the brain lining) to help researchers learn what works and how best to treat it. You may be asked for blood/tissue samples and a procedure to collect spinal fluid when brain metastases are diagnosed.
This study looks at how solid tumors spread to the lining of the brain and spinal cord. It aims to understand this condition better by reviewing patient records.
This study uses brain biopsy and spinal fluid (lumbar puncture) tests to better diagnose and understand how well treatments may work for certain lymphomas in the brain. It may help doctors match the right therapy by studying what the disease looks like in the body and brain.
This trial looks at spinal fluid (also called CSF) in adults with EGFR-mutant lung cancer that has spread to the lining around the brain/spinal cord. The goal is to better understand the disease and what the spinal fluid tests may show to guide care.
This trial uses a special test on spinal fluid to guide treatment for brain cancers. It aims to see if measuring tumor DNA in the fluid can help doctors decide on the best therapy for you.
This study looks at spinal fluid (cerebrospinal fluid, or CSF) to find markers that may signal a brain or spinal tumor or related abnormal growth. If you have a suspected tumor near the CSF spaces, these results may help doctors better classify what’s going on.
Hear when a new Brain Metastasases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.